File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1111/j.1600-0501.2007.01377.x
- Scopus: eid_2-s2.0-34547181757
- PMID: 17355354
- WOS: WOS:000247240800003
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Adjunctive local antibiotic therapy in the treatment of peri-implantitis II: Clinical and radiographic outcomes
Title | Adjunctive local antibiotic therapy in the treatment of peri-implantitis II: Clinical and radiographic outcomes |
---|---|
Authors | |
Keywords | Antibiotics Cumulative interceptive supportive therapy (CIST) Inflammation Local drug delivery Oral implants Peri-implantitis |
Issue Date | 2007 |
Publisher | Wiley-Blackwell Publishing, Inc.. The Journal's web site is located at http://www.blackwellpublishing.com/journals/CLR |
Citation | Clinical Oral Implants Research, 2007, v. 18 n. 3, p. 281-285 How to Cite? |
Abstract | Aim: To monitor over 12 months clinical and radiographic changes occurring after adjunctive local delivery of minocycline microspheres for the treatment of peri-implantitis. Material and methods: In 25 partially edentulous subjects, 31 implants diagnosed with peri-implantitis were treated. Three weeks after oral hygiene instruction, mechanical debridement and local antiseptic cleansing using 0.2% chlorhexidine gel, baseline (Day 0) parameters were recorded. Minocycline microspheres (Arestin®) were locally delivered to each implant site with bone loss and a probing pocket depth (PPD) ≥5 mm. Rescue therapy with Arestin® was allowed at Days 180 and 270 at any site exhibiting an increase in PPD≥2 mm from the previous visit. The following clinical parameters were recorded at four sites/implant at Day 0, 10, 30, 60, 90, 180, 270 and 360: PPD, clinical attachment level (CAL), bleeding on probing (BOP) and plaque index (PlI). Results: Six implants in six subjects were either rescued or exited because of persisting active peri-implantitis. Successful implants showed a statistically significant reduction in both PPD and percentage of sites with BOP between baseline and Day 360 (P<0.05). At mesial implant sites, the mean PPD reduction amounted to 1.6 mm (95% CI: 0.9-2.2 mm, P<0.001) and was accompanied by a statistically significant reduction of the BOP value (P<0.001). Binary regression analysis showed that the clinical parameters and smoking history could not discriminate between successfully treated and rescued or exited implants at any observation time point. Conclusion: Non-surgical mechanical treatment of peri-implantitis lesions with adjunctive local delivery of microencapsulated minocycline led to positive effects on clinical parameters up to 12 months. © 2007 Blackwell Munksgaard. |
Persistent Identifier | http://hdl.handle.net/10722/154472 |
ISSN | 2023 Impact Factor: 4.8 2023 SCImago Journal Rankings: 1.865 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Salvi, GE | en_US |
dc.contributor.author | Persson, GR | en_US |
dc.contributor.author | HeitzMayfield, LJA | en_US |
dc.contributor.author | Frei, M | en_US |
dc.contributor.author | Lang, NP | en_US |
dc.date.accessioned | 2012-08-08T08:25:31Z | - |
dc.date.available | 2012-08-08T08:25:31Z | - |
dc.date.issued | 2007 | en_US |
dc.identifier.citation | Clinical Oral Implants Research, 2007, v. 18 n. 3, p. 281-285 | en_US |
dc.identifier.issn | 0905-7161 | en_US |
dc.identifier.uri | http://hdl.handle.net/10722/154472 | - |
dc.description.abstract | Aim: To monitor over 12 months clinical and radiographic changes occurring after adjunctive local delivery of minocycline microspheres for the treatment of peri-implantitis. Material and methods: In 25 partially edentulous subjects, 31 implants diagnosed with peri-implantitis were treated. Three weeks after oral hygiene instruction, mechanical debridement and local antiseptic cleansing using 0.2% chlorhexidine gel, baseline (Day 0) parameters were recorded. Minocycline microspheres (Arestin®) were locally delivered to each implant site with bone loss and a probing pocket depth (PPD) ≥5 mm. Rescue therapy with Arestin® was allowed at Days 180 and 270 at any site exhibiting an increase in PPD≥2 mm from the previous visit. The following clinical parameters were recorded at four sites/implant at Day 0, 10, 30, 60, 90, 180, 270 and 360: PPD, clinical attachment level (CAL), bleeding on probing (BOP) and plaque index (PlI). Results: Six implants in six subjects were either rescued or exited because of persisting active peri-implantitis. Successful implants showed a statistically significant reduction in both PPD and percentage of sites with BOP between baseline and Day 360 (P<0.05). At mesial implant sites, the mean PPD reduction amounted to 1.6 mm (95% CI: 0.9-2.2 mm, P<0.001) and was accompanied by a statistically significant reduction of the BOP value (P<0.001). Binary regression analysis showed that the clinical parameters and smoking history could not discriminate between successfully treated and rescued or exited implants at any observation time point. Conclusion: Non-surgical mechanical treatment of peri-implantitis lesions with adjunctive local delivery of microencapsulated minocycline led to positive effects on clinical parameters up to 12 months. © 2007 Blackwell Munksgaard. | en_US |
dc.language | eng | en_US |
dc.publisher | Wiley-Blackwell Publishing, Inc.. The Journal's web site is located at http://www.blackwellpublishing.com/journals/CLR | en_US |
dc.relation.ispartof | Clinical Oral Implants Research | en_US |
dc.subject | Antibiotics | - |
dc.subject | Cumulative interceptive supportive therapy (CIST) | - |
dc.subject | Inflammation | - |
dc.subject | Local drug delivery | - |
dc.subject | Oral implants | - |
dc.subject | Peri-implantitis | - |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Aged | en_US |
dc.subject.mesh | Alveolar Bone Loss - Drug Therapy - Etiology - Radiography | en_US |
dc.subject.mesh | Anti-Bacterial Agents - Therapeutic Use | en_US |
dc.subject.mesh | Dental Implants - Adverse Effects | en_US |
dc.subject.mesh | Epidemiologic Methods | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Mandibular Diseases - Drug Therapy - Etiology - Radiography | en_US |
dc.subject.mesh | Maxillary Diseases - Drug Therapy - Etiology - Radiography | en_US |
dc.subject.mesh | Middle Aged | en_US |
dc.subject.mesh | Minocycline - Therapeutic Use | en_US |
dc.title | Adjunctive local antibiotic therapy in the treatment of peri-implantitis II: Clinical and radiographic outcomes | en_US |
dc.type | Article | en_US |
dc.identifier.email | Lang, NP:nplang@hkucc.hku.hk | en_US |
dc.identifier.authority | Lang, NP=rp00031 | en_US |
dc.description.nature | link_to_subscribed_fulltext | en_US |
dc.identifier.doi | 10.1111/j.1600-0501.2007.01377.x | en_US |
dc.identifier.pmid | 17355354 | - |
dc.identifier.scopus | eid_2-s2.0-34547181757 | en_US |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-34547181757&selection=ref&src=s&origin=recordpage | en_US |
dc.identifier.volume | 18 | en_US |
dc.identifier.issue | 3 | en_US |
dc.identifier.spage | 281 | en_US |
dc.identifier.epage | 285 | en_US |
dc.identifier.isi | WOS:000247240800003 | - |
dc.publisher.place | United States | en_US |
dc.identifier.scopusauthorid | Salvi, GE=35600695300 | en_US |
dc.identifier.scopusauthorid | Persson, GR=7101853867 | en_US |
dc.identifier.scopusauthorid | HeitzMayfield, LJA=6602309146 | en_US |
dc.identifier.scopusauthorid | Frei, M=17345791500 | en_US |
dc.identifier.scopusauthorid | Lang, NP=7201577367 | en_US |
dc.identifier.citeulike | 1313243 | - |
dc.identifier.issnl | 0905-7161 | - |